title: [Safety of the proton pump inhibitors].
abstract: Proton Pump Inhibitors (PPI) are consumed by millions of people around the world, either by prescription or self-medication, some medications of this group are Over-the-counter (OTC) medicines. PPIs have been associated with hypergastrinemia, rebound acid hypersecretion, malabsorption, osteoporosis and infections. This is an updated review of clinical pharmacology aspects of IPBS, with emphasis on safety aspects.
authors.affiliation: Universidad Nacional Mayor de San Marcos, Jefe del Servicio de Geriatría del Hospital Almenara, Lima Perú. teodoroscanoa@yahoo.com
authors.forename: Teodoro Julio
authors.initials: TJ
authors.lastname: Oscanoa Espinoza
mesh_terms: D005744:Gastric Acid / Q000378:metabolism; D006801:Humans; D054328:Proton Pump Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D054328:Proton Pump Inhibitors